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CDC5 is a MYB-related protein that exists in plants, animals, and
fungi. In Arabidopsis, CDC5 regulates both growth and immunity
through unknown mechanisms. Here, we show that CDC5 from
Arabidopsis positively regulates the accumulation of microRNAs
(miRNAs), which control many biological processes including de-
velopment and adaptations to environments in plants. CDC5 inter-
acts with both the promoters of genes encoding miRNAs (MIR) and
the DNA-dependent RNA polymerase II. As a consequence, lack of
CDC5 reduces the occupancy of polymerase II atMIR promoters, as
well as MIR promoter activities. In addition, CDC5 is associated
with the DICER–LIKE1 complex, which generates miRNAs from
their primary transcripts and is required for efficient miRNA pro-
duction. These results suggest that CDC5 may have dual roles in
miRNA biogenesis: functioning as a positive transcription factor of
MIR and/or acting as a component of the DICER–LIKE1 complex to
enhance primary miRNA processing.
MicroRNAs (miRNAs) and small interfering RNAs (siRNAs)are ∼22-nucleotide (nt) noncoding RNAs that regulate va-
rious biological processes including development, metabolism, and
immunity in plants and animals (1–3). miRNAs are generated from
primary miRNA transcripts (pri-miRNAs) containing stem–loop
structure, whereas siRNAs are derived from long, perfect, double-
stranded RNAs (dsRNAs) (1–3). They are associated with mem-
bers of the Argonaute protein family to repress gene expression at
posttranscriptional and/or transcriptional levels (1–3). In addition
to miRNAs, plants encode two major classes of siRNAs: siRNAs
derived from repeated DNAs (ra-siRNAs) and transacting siRNAs
(ta-siRNAs) (4–6).
Studies in Arabidopsis have established the framework of
miRNA biogenesis in plants (1–3). In Arabidopsis, pri-miRNAs
are primarily transcribed by DNA-dependent RNA polymerase
II (Pol II), with assistance from the mediator complex and the
transcription factor Negative on TATA less2 (NOT2) (7, 8).
After transcription, pri-miRNAs are processed by an RNase III
enzyme called DICER–LIKE1 (DCL1) to miRNA precursors
and then to mature miRNAs (9, 10). The efficient processing
of pri-miRNA requires SERRATE (SE; a zinc finger protein),
TOUGH (an RNA-binding protein), and a dephosphorylated
HYPONASTIC LEAVES1 (HYL1; a double-stranded RNA
binding protein) that form a complex with DCL1 (11-18). SE and
HYL1 also promote the processing accuracy of pri-miRNAs
(19). Four other proteins, DAWDLE (DDL; an RNA binding
protein), Cap-binding protein 20, Cap-binding protein 80, and
NOT2, which are associated with the DCL1 complex (8, 20–22),
also function in miRNA biogenesis. Recent studies also reveal
that the correct localization of DCL1 requires NOT2 and
MODIFIER OF SNC1, 2 (an RNA binding protein) (8, 23).
In addition, the accumulation of a subset of miRNAs requires
a proline-rich protein named SICKLE (24).
The cell division cycle 5 (CDC5) protein is a conserved protein
in animals, plants, and fungi (25). It was first isolated from
Schizosaccharomyces pombe as a cell cycle regulator. CDC5 is
considered a putative transcription factor, as it is a MYB (a
transcription factor)-related protein (26–28). In human and yeast,
CDC5 has been shown to act as a component of spliceosome to
participate in mRNA splicing (29, 30). In Arabidopsis, CDC5
binds DNA and is required for development and immunity to
bacteria infection (31, 32). However, how CDC5 functions in
Arabidopsis is unclear.
Here, we show that CDC5 plays important roles in the bio-
genesis of miRNAs and siRNAs in Arabidopsis. CDC5 interacts
with both Pol II and the promoters of genes encoding miRNAs
(MIR). As a consequence, impairment of CDC5 reduces theMIR
promoter activity and the occupancy of Pol II at the MIR pro-
moter. In addition, CDC5 is associated with the DCL1 complex
and is required for efficient miRNA production. On the basis of
these results, we propose that CDC5 positively regulates the
transcription and/or processing of pri-miRNAs.
Results
CDC5 Is Required for the Accumulation of miRNAs and siRNAs. In
cdc5-1, a T-DNA insertion disrupts the expression of CDC5,
resulting in multiple developmental defects such as smaller plant
size, altered leaf shape, late flowering, and sterility (31, 32). We
reasoned that cdc5-1 might impair miRNA accumulation, as
the alteration in miRNA levels often causes pleiotropic de-
velopmental defects (33, 34). We thus performed Northern blot
analysis to examine miRNA abundance in inflorescences of cdc5-1
and Columbia-0 (Col; wild-type control). The levels of all examined
miRNAs (miR166/165, miR167, miR159/319, miR390, miR171,
miR172, miR173, miR156, and miR163) were reduced in cdc5-1
compared with those in Col (Fig. 1A and Fig. S1A). A CDC5-YFP
transgene driven by the CDC5 promoter (pCDC5::CDC5-YFP) fully
restored miRNA levels (Fig. S2A), demonstrating that cdc5-1 is
responsible for the reduction of miRNA abundance. In addi-
tion, cdc5-1 exhibited a similar effect on the levels of several
examined miRNAs in leaves as those in inflorescences (Fig. 1B
and Fig. S1B). We also tested the effect of cdc5-1 on the ac-
cumulation of endogenous siRNAs, including two ta-siRNAs,
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TAS1-siR255 and TAS2-siR1511, and five siRNAs derived from
ra-siRNAs, siR02, siR1003, cluster 4, IR71, and TR2588. The
levels of these siRNAs were lower in cdc5-1 than those in Col
(Fig. 1C and Fig. S1C).
We next examined the effects of cdc5-1 on miRNA and ta-
siRNA function by analyzing the expression levels of their tar-
gets, using quantitative RT-PCR (qRT-PCR). The transcript
levels of several examined targets (ARF8, CUC1, MYB65, PPR,
SPL6, SPL10, and ARF3) were moderately increased in cdc5-1
relative to those in Col (Fig. S2B).
CDC5 Regulates the Transcription of MIR.We next performed qRT-
PCR to examine the levels of seven pri-miRNAs (pri-miR158a,
pri-miR159a, pri-miR167a, pri-miR171a, pri-miR172a, pri-
miR172b, and pri-miR173) in Col and cdc5-1. The levels of
these pri-miRNAs decreased in cdc5-1 compared with those in
Col (Fig. 2A). The reduced levels of pri-miRNAs and miRNAs
in cdc5-1 can result from impaired transcription of pri-miRNAs.
Alternatively, it can be a consequence of reduced stability and rapid
degradation of pri-miRNAs by nonspecific nucleases, degradation
of mature miRNAs, or enhanced posttranscriptional processing
of pri-miRNAs in cdc5-1. To test these alternative explanations,
we first determined whether CDC5 regulates MIR transcription by
examining the effect of cdc5-1 on the expression of a GUS reporter
gene driven by theMIR172b promoter (pMIR172b::GUS) (20). We
have previously used this system to determine the function of DDL
in regulating MIR transcription (20). If CDC5 is indeed a positive
transcription regulator of MIR, cdc5-1 will reduce the expression
levels of GUS. We crossed cdc5-1 with a Col transgenic line, which
contains the pMIR172b::GUS transgene (20). In the second (F2)
generation, we obtained CDC5+ (CDC5/CDC5 or CDC5/cdc5) and
cdc5-1 genotypes containing pMIR172b::GUS. GUS staining on
these plants revealed that the GUS activity was lower in cdc5-1 than
that in CDC5+ (Fig. 2B). qRT-PCR analysis confirmed that
the GUS mRNA levels in cdc5-1 were reduced relative to
those in CDC5+(Fig. 2C).
CDC5 Is Required for Pol II Occupancy at the Promoter of MIR. To
confirm that CDC5 is a positive transcription factor of MIR, we
monitored the occupancy of RNA Pol II at the promoters of
MIR166a, MIR167a, MIR171a, and MIR172b in cdc5-1 and Col
by chromatin immunoprecipitation (ChIP), using an antibody
against the second largest subunit of Pol II (RPB2), as described
by Kim et al. (7). We included a no-antibody ChIP as a negative
control. After ChIP, the MIR166a, MIR167a, MIR171a, and
MIR172b promoter fragments were examined by qPCR. As pre-
viously reported (7), the promoter regions of these fourMIRs, but
not Pol II C1 (a genomic fragment between genes At2g17470
and At2g17460) (7), were enriched in RPB2 immunoprecipitates
relative to the no-antibody control in Col. cdc5-1 reduced the
occupancy of Pol II at these regions relative to Col (Fig. 3 A and
B). Because the transcript levels of DCL1 are not affected in
cdc5-1 (described in CDC5 Is Associated with the DCL1 Complex),
we also included it as a negative control for the ChIP assay. The
association of Pol II with DCL1 promoter did not significantly
change in cdc5-1 (Fig. 3C). These data further supported that
CDC5 positively regulates MIR transcription in Arabidopsis.
However, we cannot rule out the possibility that CDC5 also
regulates the transcription of some protein-coding genes.
CDC5 Interacts with MIR Promoters. Because CDC5 is a putative
MYB domain-containing transcription factor and has a DNA
binding activity (27), we next examined whether CDC5 binds the
promoter of MIRs. We performed ChIP, using an antibody
against YFP on the cdc5-1 complementation line containing
pCDC5::CDC5-YFP (Fig. S1A) and Col. qPCR analysis showed
that MIR166a, MIR167a, MIR171a, and MIR172b promoter
fragments were enriched in the CDC5–YFP complex, but not in
the Col and no-antibody controls (Fig. 3 D and E). In addition,
CDC5 did not bind the promoter of DCL1 (Fig. 3F). These
results suggested that CDC5 is associated with MIR promoters.
CDC5 Interacts with Pol II. The association of CDC5 with MIR
promoters and the reduced Pol II occupancy at MIR promoters
in cdc5-1 suggest that CDC5 may positively regulate MIR tran-
scription by promoting the recruitment of Pol II to their pro-
moters, which predicts a potential CDC5–Pol II interaction.
Thus, we tested the association of CDC5 with Pol II through
reciprocal coimmunoprecipitation (co-IP). We extracted pro-
teins from the cdc5-1 complementation line expressing pCDC5::
CDC5-YFP and a Col control expressing a YFP transgene. IP was
performed with either anti-YFP antibody or anti-RPB2 antibody.
Western blots detected RPB2 in the CDC5–YFP complex and
CDC5–YFP in the RPB2 immunoprecipitates, respectively (Fig. 4
A and B). In contrast, the interaction between YFP and RPB2
were not detected (Fig. 4 A and B). In addition, protein G beads
without antibody failed to pull down either CDC5–YFP or RPB2.
Both CDC5 and Pol II bind DNAs, suggesting that the CDC5–
Pol II interaction may depend on DNA. However, DNase I
treatment during IP had no obvious effect on CDC5–Pol II
Fig. 1. cdc5-1 reduces the accumulation of miRNAs and siRNAs. (A) miRNA abundance in inflorescences of cdc5-1 and Col. (B) miRNA abundance in leaves of
cdc5-1 and Col. (C) siRNA abundance in inflorescences cdc5-1 and Col. Col: wild-type control of cdc5-1. U6: spliceosomal RNA U6. Small RNAs were detected by
Northern blot. After Northern blot, the radioactive signals were detected with phosphor imager and quantified with ImageQuant (V5.2). To determine
relative abundance of small RNAs in cdc5-1, the amount of a miRNA or siRNA in cdc5-1 was normalized to U6 RNA and compared with that in Col. Value of
miRNAs or siRNAs in Col was set as 1. The number below cdc5-1 indicated the relative abundance of miRNAs or siRNAs, which is the average value of three
repeats. P < 0.05; except for siR255 in Fig. 1C (t test). For miR159/319, the upper band was miR159 and the lower band was miR319.
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interaction (Fig. 4C). These results suggested that the CDC5–
Pol II association might be DNA-independent.
CDC5 Is Required for the Accumulation of miR162 in an in Vitro Assay.
We next asked whether CDC5 could function after MIR tran-
scription by examining the effect of cdc5-1 on the accumulation
of miRNAs in an in vitro processing assay (13, 35). In this in vitro
processing assay, a portion of pri-miR162b that contains the
predicted stem–loop of miR162b with 6-nt arms at each end
(MIR162b; Fig. 5A) was used. A radioactive-labeled MIR162b
probe was generated by in vitro transcription under the presence
of [α-32P] UTP. Radioactive-labeled MIR162b was then in-
cubated with protein extracts from young flower buds of either
cdc5-1 or Col, respectively. After reactions were stopped at 50,
100, and 150 min, RNAs were extracted and resolved on a de-
naturing polyacrylamide gel. The protein extracts of cdc5-1
generated less miR162b than that of Col (Fig. 5B). Quantitative
analysis at the 100-min point showed that the abundance of
miR162 in cdc5-1 was ∼50% that in Col (Fig. 5C). These results
suggested that CDC5 might have roles in miRNA biogenesis
other than acting as a MIR transcription factor.
CDC5 Is Associated with the DCL1 Complex. To determine how
CDC5 acts after MIR transcription, we first examined whether
cdc5-1 affected the transcript levels of several known genes in-
volved in miRNA biogenesis, including CBP80, CBP20, DDL,
HYL1, DCL1, HEN1, and SE, by qRT-PCR. The expression
levels of these genes were slightly increased in cdc5-1 relative to
Col (Fig. S3A). Western blot analysis showed that the protein
levels of DCL1 and HYL1 were comparable in cdc5-1 to those
seen in Col (Fig. S3 B and C).
Next we tested the interaction of CDC5 with the DCL1
complex through a bimolecular fluorescence complementation
(BiFC) assay. We have previously used this assay to determine
the association of TOUGH with the DCL1 complex (13). The
protein partners were fused to the N-terminal fragment of
Venus (nVenus) or C-terminal fragment of cyan fluorescent
protein (cCFP) under the control of a Cauliflower mosaic virus
35S promoter and cointroduced into Nicotiana benthamiana. In
this assay, generation of a functional yellow fluorescent protein
(YFP) indicates the potential interaction between proteins (36).
The CDC5–DCL1, CDC5–SE, and SE–DCL1 (positive control),
but not AGO1–CDC5 (negative control), interactions were ob-
served (Fig. 6A). In addition, weak YFP signals were produced
from the CDC5–HYL1 pair, indicating either a weak or no in-
teraction between CDC5 and HYL1 (Fig. 6A).
We performed a co-IP assay to confirm the BiFC results. The
DCL1–YFP fusion protein and YFP were expressed in N. ben-
thamiana, respectively, whereas recombinant CDC5 fused with
a maltose-binding protein epitope tag at its N terminus (MBP–
CDC5) and MBP were expressed in Escherichia coli BL21 (13).
Next, anti-YFP antibody conjugated with protein G agarose
beads was incubated with the protein mixture containing MBP–
CDC5/DCL–YFP, MBP–CDC5/YFP, or MBP/DCL1–YFP to
capture the DCL1–YFP or YFP complex. We were able to de-
tect MBP–CDC5, but not MBP, in the DCL1–YFP complex
(Fig. 6C). In contrast, YFP did not pull down either MBP or
MBP–CDC5 (Fig. 6C). In addition, RNase A treatment did not
impair the CDC5–DCL1 interaction, although it abolished an
RNA-mediated AGO4–FDM1 interaction (Fig. 6C and Fig.
S3D). These results indicated that the CDC5–DCL1 interaction
may not be RNA-mediated.
We further determined the protein domains of DCL1 that
mediate the DCL1–CDC5 interaction. Five different DCL1
fragments named F1 (aa 1–468, covering amino terminus to
helicase domain 1), F2 (aa 465–840; helicase domain 2), F3
(aa 835–1330; domain of unknown function and Piwi/Argo-
naute/Zwille domain), F4 (aa 1328–1700; RNase IIIa+IIIb
domains), and F5 (aa 1729–1909; dsRNA binding domains I+II)
were expressed in N. benthamiana, respectively, as described (37;
Fig. 6B). CDC5–YFP was able to pull down F2 (Helicase domain
2) and F5 (dsRNA binding domains I+II), but not other frag-
ments (Fig. 6D).
We next examined the interactions of CDC5 with SE and
HYL1. CDC5 and SE, but not CDC5 and HYL1, were able to
pull down each other, which was not affected by RNase A
treatment (Fig. 6 E and F). In addition, the interactions among
controls were not detected (Fig. 6 E and F). The interaction of
CDC5 with SE and DCL1 suggested that CDC5 is a component
of the DCL1 complex. However, we did not detect the HYL1–
CDC5 interaction (Fig. 6F). This was not unexpected, as CDC5
may be weakly associated with the DCL1 complex, or its asso-
ciation with HYL1 may need bridge proteins. In fact, NOT2 has
been shown to interact with DCL1 and SE, but not HYL1 (8).
Discussion
In conclusion, we show that CDC5, a MYB-related and evolu-
tionarily conserved protein, is an important player in miRNA bio-
genesis. This is evidenced by reduced levels of pri-miRNAs and less
accumulation of miRNAs in cdc5-1. Impairment of CDC5 function
Fig. 2. cdc5-1 reduces the promoter activity ofMIR. (A) The transcript levels
of various pri-miRNAs in inflorescences of cdc5-1 and Col determined by qRT-
PCR. The abundance of pri-miRNAs in cdc5-1 was normalized to that of
UBQUITIN5 (UBQ5) and compared with that in Col. Value of Col was set to 1.
SD of three technical replications was shown as error bars. (B) The levels of
GUS in CDC5+ and cdc5-1 harboring pMIR172b::GUS. CDC5+:CDC5/CDC5, or
CDC5/cdc5-1. Twenty plants containing GUS were analyzed for each of
CDC5+ and cdc5-1 genotypes. An image for each genotype is shown. (C) The
transcript levels of GUS driven by MIR172b promoter in CDC5+ and cdc5-1.
GUS transcript levels were determined by qRT-PCR. The GUS mRNA levels in
cdc5-1 were normalized to UBQ5 and compared with those in CDC5+. *P <
0.05, **P < 0.01, and ***P < 0.001 (t test).
17590 | www.pnas.org/cgi/doi/10.1073/pnas.1310644110 Zhang et al.
causes both immunity and pleiotropic development defects, which
agrees with the crucial roles of miRNAs in regulating multiple bi-
ological processes (31, 32). However, it is possible that the regu-
lation of genes other than small RNAs by CDC5 also contributes to
the observed phenotypes in cdc5-1.
On the basis of studies of CDC5 homologs in other organisms,
the roles of plant CDC5 in transcription have been speculated
(31, 32). This study provides direct evidence to support the
theory that CDC5 is a positive transcription factor. Tthat CDC5
does not bind the DCL1 promoter and that cdc5-1 does not
significantly affect the occupancy of Pol II at the DCL1 promoter
suggest that CDC5 may not be a general transcription factor.
Rather, it may affect the expression of MIRs. It is possible that
CDC5 can also act as a transcription factor for some protein-
coding genes. Given that CDC5 interacts with Pol II and Pol II
binds DNA promoter sequences, it is possible that the DNA
amplified by qPCR in the CDC5 ChIP was bound to Pol II,
rather than to CDC5. However, this seems not to be the case, as
MIR promoters, but not the Pol II-dependent DCL1 promoter,
were predominately enriched in the CDC5 ChIP. Lack of CDC5
in cdc5-1 reduces MIR promoter activity and the occupancy of
Pol II at MIR promoters, suggesting that CDC5 may have a di-
rect role in promoting the transcription of MIR by recruiting Pol
II to their promoters. It is possible that CDC5 also contributes to
Pol II activity through its interaction with Pol II. However,
cdc5-1 does not significantly affect DCL1 transcript levels, as
well as the occupancy of Pol II at its promoter, suggesting that
the CDC5–Pol II interaction by itself maybe not sufficient to
regulate the Pol II activity. Whether the CDC5–Pol II in-
teraction is required for the regulation of MIR transcription
needs to be further investigated.
CDC5 may also have a role in promoting miRNA maturation.
This is unlikely to be caused by the reduced transcription of key
genes involved in miRNA biogenesis, as their transcript levels
are slightly increased in cdc5-1. Rather, CDC5 may act as
a component of the DCL1 complex to enhance pri-miRNA
processing efficiency on the basis of the association of CDC5
with the DCL1 complex and the fact that cdc5-1 reduces the
production of miR162 in vitro. CDC5 interacts with the helicase
and dsRNA binding domains of DCL1, which regulate DCL1
activity (10, 38). Structure studies have revealed that the in-
teraction of human dicer with other proteins can cause dicer
conformational change, and therefore improve its activity (39).
Thus, it is possible that CDC5 may regulate pri-miRNA pro-
cessing through its interaction with DCL1.
In summary, our study reveals that CDC5 can positively reg-
ulate processing and/or transcription of pri-miRNAs. It is un-
likely that CDC5 regulates the transcription of all MIRs, as it is
not a general transcription factor. Thus, CDC5 may only regulate
some pri-miRNAs at both transcriptional and posttranscriptional
Fig. 3. CDC5 is required for the recruitment of Pol II to MIR promoters. (A–C) The occupancy of Pol II at various promoters detected by ChIP using anti-RBP2
antibody in cdc5-1 and Col. (D–F) The association of CDC5 with various promoters detected by ChIP using anti-YFP antibody in plants containing pCDC5::CDC5-
YFP. DNA copurified with CDC5 or Pol II was analyzed with qRT-PCR. The intergenic region between At2g17470 and At2g17460 (Pol II C1) that is not occupied
by Pol II was used as a negative control. ChIP with no antibodies was performed as another control. Means and standard derivations of three technical repeats
are presented, and three biological replicates gave similar results. Please note that the results of Pol II C1 in RBP2 ChIP (A and B) and in CDC5 ChIP (D and E)
were showed twice, respectively, for control purposes. *P < 0.05 (t test).
Fig. 4. CDC5 interacts with Pol II. (A and B) Co-IP between CDC5–YFP and Pol II. (C) Co-IP between CDC5–YFP and Pol II is DNA-independent. Protein extracts
isolated from inflorescences of plants containing CDC5–YFP or YFP were used to perform IP, using either Anti-YFP or Anti-RBP2. YFP, CDC5–YFP, and RBP2
were detected by Western blot, using anti-YFP antibody and anti-RPB2, respectively, and labeled on the left side of the picture. Two percent of input proteins
were used for RPB2, whereas 20% input proteins were used for YFP and DCL1–YFP, respectively.
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levels. However, CDC5 may have a general role in regulating pri-
miRNA processing, as it acts as cofactor of DCL1. In addition,
CDC5 is predominantly expressed in the proliferating cells (32),
suggesting that CDC5 may have cell-specific activities on miRNA
accumulation. CDC5 is required for the accumulation of ra-
siRNAs and ta-siRNAs. It is unclear whether CDC5 has a direct
role in ta-siRNA biogenesis, as the generation of ta-siRNAs
requires miRNAs. On the basis of the function of CDC5 in the
miRNA pathway, CDC5 may have two contributions, which are
not mutually exclusive, to the production of ra-siRNAs. First,
it may affect Pol IV activity, which is thought to produce the
precursor RNAs of ra-siRNAs. Second, it may regulate the DCL3
activity that generates 24-nt ra-siRNAs from long dsRNAs.
Clearly, these two possibilities need to be examined in the
near future.
Materials and Methods
Plant Materials. The cdc5-1 (SAIL_207_F03) mutant that is in the Columbia
genetic background was obtained from the Arabidopsis Biological Resources
Center (31, 32). Transgenic line harboring pMIR172b::GUS (20) was crossed to
cdc5-1. In F2 generation, CDC5+ (CDC5/CDC5 and CDC5/cdc5-1) and cdc5-1
containing pMIR172b::GUS were identified by genotyping of cdc5-1 and GUS.
RNA Analysis. Northern blot analysis of small RNAs and qRT- PCR analysis of
pri-miRNA and miRNA target transcription levels were performed as de-
scribed (13).
Plasmid Construction. A ∼5.2-Kb genomic DNA covering the CDC5 coding
region and promoter was PCR amplified from Col genomic DNA and cloned
to pMDC204 to generate the pCDC5::CDC5-YFP construct. A full-length CDC5
cDNA was amplified by RT-PCR and ligated to pMAL-c5x (New England
Biolabs) to produce the MBP-CDC5 plasmid.CDC5 cDNA was cloned into
pSAT4-C-CFP. The CDC5-C-CFP fragment was then released by I-SceI restriction
enzyme digestion and subsequently cloned into the pPZP-ocs-bar-RCS2-2
vector. SE cDNA was amplified by RT-PCR and cloned into pEarleyGate203
vector to generate the SE-MYC construct. The truncated DCL1 (F1 to F5)-MYC
plasmids were obtained from the laboratory of Y. Adam Yuan (National
University of Singapore, Singapore) (12). The primers used for plasmid
construction are listed in Table S1.
Fig. 5. cdc5-1 reduces the accumulation of miR162 in an in vitro processing
assay. (A) Schematic diagram of the pri-miR162b fragment (MIR162b) used in
the in vitro processing assay. (B)MIR162b processing by protein extracts from
cdc5-1 and Col. After reaction, RNAs were extracted, resolved on PAGE gel,
and detected with a phosphor imager. (C) Quantification of miR162 pro-
duction in cdc5-1 relative to Col. The quantitative analysis was performed for
the reaction stopped at 100 min, as shown in B. The radioactive signal of
miR162 was quantified with ImageQuant (V5.2) and then normalized to
input to determine the amount of miR162 produced by cdc5-1 or Col protein
extracts (miR162cdc5-1 or miR162Col). The relative level of miR162 produced
by cdc5-1 was calculated as miR162cdc5-1 divided by miR162Col. The value of
miR162Col was set as 1. The value represents mean of three repeats. ***P <
0.001 (t test).
Fig. 6. CDC5 interacts with the DCL1 complex. (A) BiFC analysis of CDC5
with DCL1, SE, HYL1, and AGO1. Respective pairs of cCFP (cCFP–CDC5, cCFP–
SE) and nVenus (nVenus–DCL1, nVenus–HYL1, nVenus–SE, and nVenus–
AGO1) fused proteins were coinfiltrated into N. benthamiana leaves. Yellow
fluorescence (green in image) signals were examined at 48 h after in-
filtration by confocal microscopy. Arrow indicates the BiFC signal. The red
spot was inflorescence from chlorophyll. Thirty nuclei were examined for
each pair, and an image is shown. (B) Schematic diagram of DCL1 domains
and truncated DCL1 fragments used for protein interaction assay. (C)
Coimmunoprecipitation between CDC5 and DCL1. The protein pairs in the
protein extracts were indicated by the labels on the left side of and on top of
the picture. DCL1–YFP/YFP and MBP–CDC5/MBP were detected by Western
blot, using anti-YFP and anti-MBP, respectively, and labeled on the left side
of the picture. One percent input protein was used for MBP–CDC5 and MBP.
Twenty percent input proteins were used for DCL1–YFP and YFP. (D) Coim-
munoprecipitation between CDC5 with the helicase and dsRNA binding
domains of DCL1. Truncated DCL1 proteins fused with a MYC tag at their N
terminus were expressed in N. benthamiana leaves. The protein pairs in the
protein extracts were indicated by the labels on the left side of and on top of
the picture. Anti-MYC antibody was used to detect MYC fusion proteins in
Western blots. Labels on the left side of picture indicate proteins detected by
Western blot. Five percent input proteins were used for MYC tagged pro-
teins, whereas 20% inputs were used for DCL1–YFP and YFP. Please note
only one IP picture was shown for CDC5–YFP and YFP, respectively. (E and F)
Coimmunoprecipitation between CDC5 and SERRATE (SE). The protein pairs
in the protein extracts were indicated by the labels on the left side of and on
top of the picture. Proteins detected by Western blot were indicated on the
left side of the picture. Two percent of input proteins were used for SE–MYC.
Twenty percent inputs proteins were used for MBP and YFP tagged proteins.
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Plant Complementation. The pCDC5::CDC5-YFP plasmid was transformed into
CDC5/cdc5-1. The transgenic plants were selected using hygromycin re-
sistance. In T2 generation, cdc5-1 harboring pCDC5::CDC5-YFPwas identified
by genotyping of YFP and cdc5-1.
ChIP Assay. ChIP was performed as described by Kim et al. (7). Three biological
replicates were performed. Anti-RPB2 and anti-GFP and GFP variants anti-
bodies (Clontech) were used for immunoprecipitation. qPCR was performed
on DNAs copurified with Pol II or CDC5, using primers listed in Table S1.
Co-IP Assay. For the Pol II–CDC5 co-IP, protein extracts from plants expressing
pCDC5::CDC5-YFP or YFP were incubated with anti-GFP (and GFP variants;
Clontech) antibodies or anti-RBP2 coupled to protein G-agarose beads for
4 h at 4 °C. After five-time washing, the proteins in the immunoprecipitates
were subjected to Western blot analysis, using anti-GFP antibody and anti-
RBP2 antibody, respectively. For the interactions of CDC5 with components
of the DCL1 complex, MBP-CDC5 and MBP were expressed in BL21 and
extracted, following the manufacturer’s protocol (New England Biolabs),
whereas DCL1-YFP, truncated DCL1-MYC (F1–F5), SE-MYC, and YFP were
expressed in N. benthamiana (20). HYL1 and CDC5–YFP were obtained from
inflorescences of Col and plants expressing pCDC5::CDC5-YFP, respectively.
Anti-GFP (and GFP variants) and anti-MYC antibodies were used to capture
and detect corresponsive YFP- and MYC-tagged proteins, respectively. Anti-
HYL1 and anti-MBP antibodies (New England Biolabs) were used to detect
HYL1 and MBP-tagged proteins, respectively, in Western blot.
Dicer Activity Assay. MIR162b was prepared by in vitro transcription under
the presence of [α-32P] UTP. In vitro dicer activity assay was performed
according to Qi et al. (35) and Ren et al. (13). Radioactive signals were
quantified with ImageQuant (5.2).
BiFC Assay. Paired cCFP and nVenus constructs were coinfiltrated into
N. benthamiana leaves. After 48 h, yellow fluorescence signals and
chlorophyll auto fluorescence signals were exited at 488 nm and detec-
ted by confocal microscopy (Fluoview 500 workstation; Olympus) with
a narrow barrier filter (BA505–525 nm).
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Fig. S1. Quantification of microRNA (miRNA) and small interfering RNA (siRNA) abundance. (A) miRNA abundance in inflorescences of cdc5-1 and Columbia
(Col). (B) miRNA abundance in leaves of cdc5-1 and Col. (C) siRNA abundance in inflorescences cdc5-1 and Col. The amount of miRNAs or siRNAs in cdc5-1,
quantified with ImageQuant (V5.2), was normalized to spliceosomal RNA U6 and compared with that in Col (normalized to U6 as well). The value represents
mean of three repeats. A t test was used for comparison. *P < 0.05 and **P < 0.01.
Fig. S2. The effects of cdc5-1 on the accumulation of miRNAs and target transcripts. (A) CDC5 recovers the miRNA abundance in cdc5-1. U6 RNA was probed
for loading control. Number represents the relative abundance of miRNAs in Col (wild-type control), cdc5-1, and two complementation lines (cdc5-1+CDC5). (B)
cdc5-1 increases the transcript levels of miRNA and transacting siRNA targets. The levels of target transcripts in cdc5-1were normalized with UBQUITIN5 (UBQ5)
and compared with those in Col. The value of Col is 1. SDs of three technical replications are shown as error bars. A similar result was produced with an
additional biological replicate. *P < 0.05 and **P < 0.01.
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Fig. S3. The effects of cdc5-1 on the expression of several genes involved in miRNA biogenesis. (A) Transcript levels of several genes involved in miRNA
biogenesis determined by qRT-PCR in cdc5-1 and Col. UBQ5 was used as a reference control. Error bars represent SD of three technical replications. The ex-
periment was repeated once with similar results. (B) DCL1 and (C) HYL1 protein levels detected by Western blot in cdc5-1 and Col. dcl1-9 containing a truncated
DCL1 protein and hyl1-2 lacking of HYL1 were used as controls. (D) RNase A treatment abolished the AGO4–FDM1 interaction. Proteins extracts containing
myc–AGO4/GST or myc–AGO4/GST–FDM1 incubated with glutathione beads to capture GST or GST–FDM1 complex. After pull down, proteins were detected by
Western blot. The proteins detected by Western blot were labeled left side of the picture.
Table S1. Primers used in this study
Primer name Sequence (5′–3′) Applications
GUS-F CGATGTCACTCCGTATGTTATTG qRT-PCR
GUS-R CAGTTCTTTCGGCTTGTTGC
MIR166a-F TGGCTCTCTCCACTACTCAA ChIP: qPCR
MIR166a-R GACAACAGTCCCCTCAAAA
MIR167a-F CGACCCTTAAACTCTCCATAA ChIP: qPCR
MIR167a-R ACTTCACCGTAGCAGATCAA
MIR171a-F TGCTTTGGTAGTAGATGAGGTT ChIP: qPCR
MIR171a-R CGTGTGTGGTCAGGTAAGAT
MIR172b-F TATTAAGGACTTGTAGGACTCA ChIP: qPCR
MIR172b-R TAATAGTACGTACACATAAATGG
Pol II-C1-F AGTTCAATGGAGAGATGTCGAAATATG ChIP:qPCR
Pol II-C1-R AAGAGGAAAAGAAAGAGATGGAGAGA
DCL1-F1 TTCGGGAGATAACCCTAAGAAAA ChIP:qPCR
DCL1-R1 TCTCTCTTCTGGTCTGTTTTCCA
SE-pENTR-F CACCATGGCCGATGTTAATCTTCC SE–MYC
SE-pENTR-R CTACAAGCTCCTGTAATCAATAA
CDC5cds-F(KpnI) GGGGTACCATGAGGATTATGATTAAGGGAG cCFP–CDC5
CDC5cds-R(KpnI) GGGGTACCTTATGCAGAAGCTTCCATGGCT
CDC5cds-F(BamHI) CGGGATCCATGAGGATTATGATTAAGGGAG MBP–CDC5
CDC5cds-R(EcoRI) CGGAATTCTTATGCAGAAGCTTCCATGGCT
CDC5GWgF CACCACTTTCGGAGTCTCTGGATTTTC pCDC5::CDC5-YFP
CDC5GWgR TGCAGAAGCTTCCATGGCTATGGCT
cCFP, C-terminal fragment of cyan fluorescent protein; ChIP, chromatin immunoprecipitation; MBP, maltose-
binding protein; qRT-PCR, quantitative RT-PCR.
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